Beyond renoprotective impact; ameliorative effects of metformin on malignancies

• Auteurs principaux: Nozar Dorestan (Auteur), Mohammad Bahadoram (Auteur), Mohammadreza Khosravi (Auteur), Sara Bahadoram (Auteur), Mohammad Davoodi (Auteur), Maedeh Barahman (Auteur)
• Format: Livre
• Publié: Society of Diabetic Nephropathy Prevention, 2018-05-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Diabetes therapies were associated with either a reduced or increased risk of cancer. There are continuous discussions about a possible protective action of metformin. In fact, metformin, a commonly consumed anti-diabetic medication has an ameliorative impact on some cancers by direct (preventing ce...